AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 35 filers reported holding AC IMMUNE SA in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,000 | -20.0% | 2,777 | -15.8% | 0.00% | – |
| Q2 2023 | $10,000 | +233.3% | 3,299 | +179.6% | 0.00% | – |
| Q1 2023 | $3,000 | +50.0% | 1,180 | 0.0% | 0.00% | – |
| Q4 2022 | $2,000 | -33.3% | 1,180 | +18.0% | 0.00% | – |
| Q3 2022 | $3,000 | -82.4% | 1,000 | -78.3% | 0.00% | – |
| Q2 2022 | $17,000 | -37.0% | 4,600 | -32.4% | 0.00% | – |
| Q1 2022 | $27,000 | -56.5% | 6,800 | -46.3% | 0.00% | – |
| Q4 2021 | $62,000 | -38.0% | 12,659 | -15.0% | 0.00% | – |
| Q3 2021 | $100,000 | -16.0% | 14,898 | -0.7% | 0.00% | – |
| Q2 2021 | $119,000 | -39.0% | 15,004 | -41.4% | 0.00% | – |
| Q1 2021 | $195,000 | +4775.0% | 25,583 | +2711.3% | 0.00% | – |
| Q4 2020 | $4,000 | +300.0% | 910 | +381.5% | 0.00% | – |
| Q3 2020 | $1,000 | -50.0% | 189 | -61.5% | 0.00% | – |
| Q3 2019 | $2,000 | +100.0% | 491 | +94.1% | 0.00% | – |
| Q2 2019 | $1,000 | -50.0% | 253 | -41.2% | 0.00% | – |
| Q1 2019 | $2,000 | – | 430 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 1,500,000 | $24,705,000 | 2.18% |
| Monashee Investment Management LLC | 275,000 | $4,529,000 | 1.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 79,800 | $1,314,000 | 0.21% |
| Hillhouse Capital Management | 550,000 | $9,059,000 | 0.18% |
| Temasek Holdings (Private) Ltd | 1,337,500 | $22,029,000 | 0.18% |
| PointState Capital LP | 425,000 | $7,000,000 | 0.07% |
| Artal Group S.A. | 150,000 | $2,471,000 | 0.05% |
| HIGHLAND CAPITAL MANAGEMENT LP | 87,900 | $1,448,000 | 0.04% |
| Schonfeld Strategic Advisors LLC | 14,779 | $243,000 | 0.04% |
| Point72 Hong Kong Ltd | 4,000 | $66,000 | 0.04% |